The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The NZX-listed milk processor faces receivership if special meeting vote does not approve $130m shareholder loan from Bright Dairy.
Casino operator says it bought the stake for $40m in 2022 but is now not ‘strategically necessary’.
The NZX-listed retailer is taking 'decisive action internally'.
The scale of Kathmandu's sales decline through the winter trading period is surprising, analyst says.
Interests linked to Morrison chair Rob Morrison tip over the 5% disclosure threshold.
The shares soared to double the valuation put on the stock earlier in the week by Morningstar.
New Zealand King Salmon executives say they won’t be ‘gambling’ with company’s future over Blue Endeavour project.
While Christchurch Airport unveils plan for 12 new eateries and upgraded facilities at its terminal.
Financial forecasts following the kiwifruit harvest expect Seeka to turn a profit for FY24.